The sequence of the glycolytic enzymatic reactions responsible for the breakdown of glucose into two trioses and further into pyruvate or lactate was elucidated in 1940. For over seven decades it has been taught precisely the way that sequence was first described by Embden, Meyerhof and Parnas. Accordingly, two different glycolytic outcomes were proposed; the aerobic one with pyruvate as the final product, and the anaerobic one, identical to aerobic glycolysis except for one additional step, the reduction of pyruvate to lactate. While pyruvate has been presented as the mitochondrial substrate of the tricarboxylic acid cycle, lactate has regularly been vilified as a useless and frequently toxic end product of anaerobic glycolysis. Several studies in the 1980s have shown that both muscle and brain tissues are capable of oxidizing and utilizing lactate as an energy substrate, thus challenging the monocarboxylate's ill reputation. Expectedly, these findings were met with great skepticism and doubts that lactate could play any role in bioenergetics. Despite many studies from the 1920s and 1930s that have clearly showed the ability of brain tissue to oxidize lactate, even the investigators who published them assumed that lactate oxidation was simply a clearing mechanism of this end-product of anaerobic glycolysis (Schurr, 2006, 2014). Nevertheless, in the past two decades monocarboxylate transporters (MCTs) were identified and localized in both cellular and mitochondrial membranes and the existence of a lactate receptor in the brain has also been suggested (Bergersen and Gjedde, 2012). Both direct and indirect evidence now indicate that the enzyme lactate dehydrogenase (LDH) resides not only in the cytosol, as part of the glycolytic pathway machinery, but also in the mitochondrial outer membrane. The mitochondrial form of the enzyme oxidizes lactate to pyruvate and concomitantly produces the reducing agent NADH (Passarella et al., 2014; Rogatzki et al., 2015). These findings have shed light on a major drawback of the originally proposed aerobic version of the glycolytic pathway i.e., its inability to regenerate NAD+, in contrast to the anaerobic glycolysis that features a cyclical ability to regenerate NAD+upon pyruvate reduction to lactate by the cytosolic LDH. The malate-aspartate shuttle (MAS), a major redox shuttle in the brain was proposed as an alternative pathway for NAD+ generation for aerobic glycolysis. However, the necessity for MAS to fulfill such function could be questioned if the glycolytic pathway always proceeded to its end-products, lactate and NAD+, or when the suggested alternative, a lactate-malate-aspartate shuttle (Kane, 2014) is considered. An additional dilemma the originally proposed aerobic glycolysis presents, has to do with the glycolytic pathway of erythrocytes, which despite its highly aerobic environment always produces lactate as its end-product. Meanwhile, several other functions have been suggested for lactate (Chambers et al., 2014; Galow et al., 2014; Hertz et al., 2014; Brooks and Martin, 2015; Goodwin et al., 2015). For decades, pyruvate has always been the substrate of choice when measuring the rate of mitochondrial State III respiration employing an oxygen electrode. However, only recently it has been shown that lactate can be used as a substrate, too (de Bari et al., 2008; Passarella et al., 2008, 2014). Additional experiments could be designed to provide further insight into the role of lactate in energy metabolism. For example, would the addition of mitochondria to ruptured red blood cells switch their glycolytic pathway to produce pyruvate instead of lactate?
No takes yet. Share an insight, caveat, or question.
Schurr et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: